# Tempest Therapeutics, Inc.: Form 8-K, filed May 26, 2016

- Company: [Tempest Therapeutics, Inc.](/companies/tpst.md) (CIK 1544227)
- Form: 8-K
- Filed: 2016-05-26
- Accepted by EDGAR: May 26, 2016, 17:09 ET
- Period: 2016-05-26
- Accession: 0001104659-16-123724
- Inline XBRL: yes
- Main document: https://www.sec.gov/Archives/edgar/data/1544227/000110465916123724/a16-12101_48k.htm
- All documents and exhibits: https://www.sec.gov/Archives/edgar/data/1544227/000110465916123724/

## Items reported

- Item 1.01: Entry into a material agreement
- Item 8.01: Other events
- Item 9.01: Financial statements and exhibits

## Sections

Sections are extracted only from 10-K and 10-Q reports. Read this filing’s documents on sec.gov. https://www.sec.gov/Archives/edgar/data/1544227/000110465916123724/a16-12101_48k.htm

Filed May 26, 2016.
Source: SEC EDGAR, the filing index for accession 0001104659-16-123724. Last ingested by Listed: Nov 15, 2026, 00:20 ET. No prices; not investment advice.
